TrialImmunity, inflammation and disease2022
A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19.
Amir Behnam Kharazmi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled ittrialcites it